You're probably not far off from the truth BSR. Gerald and co were aiming to try and uplist last year or early this year. However, I believe with the new players on the SAB it only solidifies the notion that Gerald is getting ready to release some positive revenue related news, as the company is slowly putting all the pieces together. Then it won't be long before the uplist follows. Personally, I would like to see Gerald keep the Lympro combo and have all the BP companies pay us to use our tests. Then we could fund the other projects with continuous income.

Waiting patiently is one of the hardest things to do, especially since we are on the verge of generating some actual revenue. Ive noticed the board has gone quiet over the past several days. Everyone is ready for the show to begin.